STAAR SURGICAL COMPANY
Manufacturer adverse-event records for STAAR SURGICAL COMPANY come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1996–2026 · heavy-book · quiet Death-code · injury-heavy
Death-code intensity
STAAR SURGICAL COMPANY is quieter on Death-coded events
Death-coded event_type rows are 3 of 40,998 (0.01% · quiet tercile among 443 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for STAAR SURGICAL COMPANY
The standout signal for STAAR SURGICAL COMPANY is Death-code intensity: 0.01% of 40,998 reports (quiet tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair STAAR SURGICAL COMPANY with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 10 device types, led in this extract by Injury at 30,207 (73.7% of event_type total). Peak single-year volume reaches 5,788 reports across 30 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (10)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.